Debut Plus

30.97

+0 +0.00%

17 Jul 2026

BSE Listed

GSM 0 · ESM 1

Rekvina Laboratories Ltd. (526075)

Volume: 2,205Avg Vol 1W: 646Avg Vol 1M: 1,02852W Range:6.7546.65
Market Cap₹19 Cr
Current Price₹30.97
Previous Close₹30.97
High / Low (52w)₹46.65 / ₹6.75
Volume2,205
Avg Vol (1W)646
Avg Vol (1M)1,028
Stock P/E
Book Value₹-2.03
Dividend Yield0%
ROE20.74%
ROA-21.01%
Revenue (TTM)
Revenue Growth
Profit Margin-19.69%
Total Debt
Shares Outstanding1 Cr
Face Value
EPS (TTM)₹0
P/B0
Debt / Equity0
50 DMA₹37.91
200 DMA
Day change+0.00%
SurveillanceGSM 0 · ESM 1 (as of 2026-07-17)
Price Chart
30.97 337.43% · 1Y
46758K
2026-01-13
2026-07-16

20-day avg volume: 1K shares

Pros
  • Healthy return on equity of 20.7%.
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS
Profit & Loss (Annual)
MetricMar 2017Mar 2018Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS-0.03-0.130-0.11-0.13-0-0.03-0.23
Balance Sheet
MetricMar 2017Mar 2018Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹1 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Total Liabilities₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Equity₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Shareholding
Promoter 41.3% Institutions 0% Public 58.7%
Efficiency & Working Capital
ROCE-104.2%
Interest Coverage0
Dividend Payout
Debtor Days
Inventory Days
Payable Days
Cash Conversion Cycle
Working Capital Days
Shareholding Details

As of 2026-03-31

Promoter41.3%
FII0%
DII0%
Institutions0%
Public58.7%
Promoter Pledge0%
No. of Shareholders2,475
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters41.3%41.3%41.3%41.3%41.3%41.3%41.3%41.3%41.3%41.3%41.3%41.3%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public58.7%58.7%58.7%58.7%58.7%58.7%58.7%58.7%58.7%58.7%58.7%58.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders2,4402,4402,4402,4322,4312,4452,4302,4272,4422,4275032,475
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Surbhit Mukesh ShahShareholding of Promoter and Promoter Group15.2%9,17,607
Amit Mukesh ShahShareholding of Promoter and Promoter Group13.7%8,27,883
Mukesh Jamnadas ShahShareholding of Promoter and Promoter Group12.3%7,43,993
Niravbhai Jashubhai PatelPublic Shareholding6.5%3,89,921
Dilsan Pharma Impex Private LimitedPublic Shareholding6.4%3,85,773
Abhijit Dharmeshbhai MehtaPublic Shareholding4.5%2,69,000
Arunkumar Narsingh RaoPublic Shareholding3.9%2,37,000
Kishorbhai J SuratwalaPublic Shareholding3.8%2,29,694
Khushali Nemish BadaniPublic Shareholding2.4%1,44,175
Amitkumar Arunkumar RaoPublic Shareholding1.7%99,531
Nemishbhai Jayeshbhai BadaniPublic Shareholding1.5%90,175
Pareshkumar Rameshchandra PatelPublic Shareholding1.5%87,109
Sanjay Bhanubhai ShahPublic Shareholding1.1%65,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Amit Mukesh Shah00%2026-03-31
Surbhit Mukesh Shah00%2026-03-31
Mukesh Jamnadas Shah00%2026-03-31
Khushali Nemish Badani00%2026-03-31
Nemishbhai Jayeshbhai Badani00%2026-03-31
Amitkumar Arunkumar Rao00%2026-03-31
Kishorbhai J Suratwala00%2026-03-31
Arunkumar Narsingh Rao00%2026-03-31
Pareshkumar Rameshchandra Patel00%2026-03-31
Niravbhai Jashubhai Patel00%2026-03-31
Sanjay Bhanubhai Shah00%2026-03-31
Abhijit Dharmeshbhai Mehta00%2026-03-31
Board of Directors
NameDesignationYear
ILA RAJENDRA PATHAKChairman(Non Exe)&Dir(Non-Ind)2025
Amit Mukeshbhai ShahManaging Director2025
Surbhit ShahExecutive Director & CFO2025
Dhruval PatelIndependent Non Exe. Director2025
Nilesh Harkesh YadavIndependent Director2025
Deepak KhandelwalCompany Sec. & Compli. Officer2025
PRATEEK JAINAdditional Director2025
Jay Chintan PatelAdditional Director2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹5433
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000000
2025000000
2025000000
Substantial Acquisitions (SAST)

1 disclosure(s)

Off Market15/05/2025 - 16/05/2025 · 1,13,245
Company Information
Incorporated1988
ChairmanILA RAJENDRA PATHAK
AuditorY M Shah & Co
Investor Email[email protected]
🌐 www.rekvinalaboratories.com

📍 328 Paradise Complex, Sayajigunj, Vadodara, Gujarat, 390005

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search